オファツムマブ (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "オファツムマブ" in Japanese language version.

refsWebsite
Global rank Japanese rank
5,225th place
low place
low place
low place
4th place
24th place
low place
low place
68th place
425th place
3,823rd place
low place
6,690th place
394th place
low place
8,165th place
low place
low place
719th place
3,311th place

cancerit.jp

clinicaltrials.gov

europa.eu

ema.europa.eu

glaxosmithkline.co.jp

hc-sc.gc.ca

webprod5.hc-sc.gc.ca

  • Product Information”. Health Canada. GlaxoSmithKline Inc. (2012年8月13日). 2015年9月22日閲覧。

medicines.org.uk

medscape.com

reference.medscape.com

nih.gov

dailymed.nlm.nih.gov

ncbi.nlm.nih.gov

  • Lin, TS (2010). “Ofatumumab: a novel monoclonal anti-CD20 antibody” (PDF). Pharmacogenomics and personalized medicine 3: 51-59. PMC 3513208. PMID 23226042. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513208/pdf/pgpm-3-051.pdf. 

pubmed.ncbi.nlm.nih.gov

  • Lin, TS (2010). “Ofatumumab: a novel monoclonal anti-CD20 antibody” (PDF). Pharmacogenomics and personalized medicine 3: 51-59. PMC 3513208. PMID 23226042. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513208/pdf/pgpm-3-051.pdf. 

pmda.go.jp

info.pmda.go.jp

wikipedia.org

en.wikipedia.org

  • 臨床試験番号 NCT00611455 研究名 "Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to MTX Therapy" - ClinicalTrials.gov
  • 臨床試験番号 NCT00603525 研究名 "Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy" - ClinicalTrials.gov
  • 臨床試験番号 NCTNCT01014208 研究名 "Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma (ORCHARRD" - ClinicalTrials.gov
  • 臨床試験番号 NCT00349349 研究名 "HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab" - ClinicalTrials.gov